Figure 4. Clinical Trial Enrichment of Patients Progressing From Intermediate Age-Related Macular Degeneration (iAMD) to Geographic Atrophy (GA) Using a Deep-Learning Algorithm.

A cohort of patients recruited from the unenriched population of patients with iAMD was compared to a cohort screened and selected from large clinical databases. Comparisons are shown at 3 different estimates of incidence of progression from iAMD to GA per year (0.75%, 1.5%, and 5.0%).